(AIXA) AIXTRON SE - Overview
Sector: TechnologyIndustry: Semiconductor Equipment & Materials | Exchange XETRA (Germany) | Currency EUR | Market Cap: 4.315m | Total Return 213.1% in 12m
Stock: Deposition Equipment, Semiconductor Materials, Manufacturing
Total Rating 73
Risk 97
Buy Signal 1.95
| Risk 5d forecast | |
|---|---|
| Volatility | 62.4% |
| Relative Tail Risk | -10.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.33 |
| Alpha | 211.47 |
| Character TTM | |
|---|---|
| Beta | 0.862 |
| Beta Downside | 0.487 |
| Drawdowns 3y | |
|---|---|
| Max DD | 75.94% |
| CAGR/Max DD | 0.12 |
EPS (Earnings per Share)
Revenue
Description: AIXA AIXTRON SE March 04, 2026
AIXTRON SE supplies deposition equipment to the semiconductor industry. This sector is critical for manufacturing integrated circuits and advanced electronic components.
The companys business model includes developing, producing, and installing equipment for semiconductor material deposition. They also provide associated services such as process support, training, and customer service.
AIXTRONs products facilitate the creation of compound semiconductors and optoelectronic devices. These are used in applications like LEDs, power electronics, and data transmission, reflecting the broad utility of their specialized equipment.
For more detailed analysis, consider exploring ValueRays comprehensive reports.
Headlines to watch out for
- Silicon Carbide (SiC) power electronics demand drives equipment sales
- Gallium Nitride (GaN) power electronics adoption boosts deposition equipment orders
- Global semiconductor capital expenditure directly impacts equipment sales
- Asian market demand for advanced displays influences equipment revenue
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 85.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 24.50 > 1.0 |
| NWC/Revenue: 101.0% < 20% (prev 80.31%; Δ 20.68% < -1%) |
| CFO/TA 0.20 > 3% & CFO 208.6m > Net Income 85.2m |
| Net Debt (-100.6m) to EBITDA (113.2m): -0.89 < 3 |
| Current Ratio: 5.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (112.8m) vs 12m ago -1.46% < -2% |
| Gross Margin: 39.95% > 18% (prev 0.41%; Δ 3.95k% > 0.5%) |
| Asset Turnover: 54.08% > 50% (prev 62.17%; Δ -8.09% > 0%) |
| Interest Coverage Ratio: 120.9 > 6 (EBITDA TTM 113.2m / Interest Expense TTM 798k) |
Altman Z'' 9.53
| A: 0.54 (Total Current Assets 684.0m - Total Current Liabilities 121.9m) / Total Assets 1.04b |
| B: 0.38 (Retained Earnings 395.1m / Total Assets 1.04b) |
| C: 0.09 (EBIT TTM 96.5m / Avg Total Assets 1.03b) |
| D: 3.92 (Book Value of Equity 506.6m / Total Liabilities 129.4m) |
| Altman-Z'' Score: 9.53 = AAA |
Beneish M -3.32
| DSRI: 0.91 (Receivables 154.4m/193.4m, Revenue 556.6m/633.1m) |
| GMI: 1.04 (GM 39.95% / 41.46%) |
| AQI: 0.93 (AQ_t 0.11 / AQ_t-1 0.12) |
| SGI: 0.88 (Revenue 556.6m / 633.1m) |
| TATA: -0.12 (NI 85.2m - CFO 208.6m) / TA 1.04b) |
| Beneish M-Score: -3.32 (Cap -4..+1) = AA |
What is the price of AIXA shares?
As of March 26, 2026, the stock is trading at EUR 36.57 with a total of 1,121,307 shares traded.
Over the past week, the price has changed by +6.49%, over one month by +50.80%, over three months by +112.99% and over the past year by +213.08%.
Over the past week, the price has changed by +6.49%, over one month by +50.80%, over three months by +112.99% and over the past year by +213.08%.
Is AIXA a buy, sell or hold?
AIXTRON SE has no consensus analysts rating.
What are the forecasts/targets for the AIXA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.3 | -19.9% |
| Analysts Target Price | - | - |
AIXA Fundamental Data Overview March 22, 2026
Market Cap USD = 4.32b (3.73b EUR * 1.1562 EUR.USD)
P/E Trailing = 43.5395
P/E Forward = 18.1488
P/S = 6.7057
P/B = 4.0952
P/EG = 2.0818
Revenue TTM = 556.6m EUR
EBIT TTM = 96.5m EUR
EBITDA TTM = 113.2m EUR
Long Term Debt = 4.63m EUR (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.77m EUR (from shortTermDebt, last quarter)
Debt = 7.50m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -100.6m EUR (from netDebt column, last quarter)
Enterprise Value = 3.51b EUR (3.73b + Debt 7.50m - CCE 224.6m)
Interest Coverage Ratio = 120.9 (Ebit TTM 96.5m / Interest Expense TTM 798k)
EV/FCF = 19.33x (Enterprise Value 3.51b / FCF TTM 181.8m)
FCF Yield = 5.17% (FCF TTM 181.8m / Enterprise Value 3.51b)
FCF Margin = 32.67% (FCF TTM 181.8m / Revenue TTM 556.6m)
Net Margin = 15.31% (Net Income TTM 85.2m / Revenue TTM 556.6m)
Gross Margin = 39.95% ((Revenue TTM 556.6m - Cost of Revenue TTM 334.2m) / Revenue TTM)
Gross Margin QoQ = 46.04% (prev 38.79%)
Tobins Q-Ratio = 3.38 (Enterprise Value 3.51b / Total Assets 1.04b)
Interest Expense / Debt = 2.68% (Interest Expense 201k / Debt 7.50m)
Taxrate = 17.48% (10.2m / 58.1m)
NOPAT = 79.6m (EBIT 96.5m * (1 - 17.48%))
Current Ratio = 5.61 (Total Current Assets 684.0m / Total Current Liabilities 121.9m)
Debt / Equity = 0.01 (Debt 7.50m / totalStockholderEquity, last quarter 910.2m)
Debt / EBITDA = -0.89 (Net Debt -100.6m / EBITDA 113.2m)
Debt / FCF = -0.55 (Net Debt -100.6m / FCF TTM 181.8m)
Total Stockholder Equity = 867.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.28% (Net Income 85.2m / Total Assets 1.04b)
RoE = 9.82% (Net Income TTM 85.2m / Total Stockholder Equity 867.9m)
RoCE = 11.06% (EBIT 96.5m / Capital Employed (Equity 867.9m + L.T.Debt 4.63m))
RoIC = 9.15% (NOPAT 79.6m / Invested Capital 869.9m)
WACC = 9.00% (E(3.73b)/V(3.74b) * Re(9.01%) + D(7.50m)/V(3.74b) * Rd(2.68%) * (1-Tc(0.17)))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.11%
[DCF] Terminal Value 66.26% ; FCFF base≈181.8m ; Y1≈119.4m ; Y5≈54.6m
[DCF] Fair Price = 9.05 (EV 919.9m - Net Debt -100.6m = Equity 1.02b / Shares 112.8m; r=9.00% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 4.56 | EPS CAGR: 40.54% | SUE: 2.49 | # QB: 1
Revenue Correlation: 42.40 | Revenue CAGR: 22.05% | SUE: 2.77 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.09 | Chg7d=+0.000 | Chg30d=-0.048 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=0.63 | Chg7d=+0.000 | Chg30d=-0.008 | Revisions Net=+1 | Growth EPS=-17.1% | Growth Revenue=-4.4%
EPS next Year (2027-12-31): EPS=1.01 | Chg7d=+0.001 | Chg30d=+0.064 | Revisions Net=+7 | Growth EPS=+59.8% | Growth Revenue=+25.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.7% (Discount Rate 9.0% - Earnings Yield 2.3%)
[Growth] Growth Spread = -25.0% (Analyst -18.3% - Implied 6.7%)
P/E Trailing = 43.5395
P/E Forward = 18.1488
P/S = 6.7057
P/B = 4.0952
P/EG = 2.0818
Revenue TTM = 556.6m EUR
EBIT TTM = 96.5m EUR
EBITDA TTM = 113.2m EUR
Long Term Debt = 4.63m EUR (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.77m EUR (from shortTermDebt, last quarter)
Debt = 7.50m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -100.6m EUR (from netDebt column, last quarter)
Enterprise Value = 3.51b EUR (3.73b + Debt 7.50m - CCE 224.6m)
Interest Coverage Ratio = 120.9 (Ebit TTM 96.5m / Interest Expense TTM 798k)
EV/FCF = 19.33x (Enterprise Value 3.51b / FCF TTM 181.8m)
FCF Yield = 5.17% (FCF TTM 181.8m / Enterprise Value 3.51b)
FCF Margin = 32.67% (FCF TTM 181.8m / Revenue TTM 556.6m)
Net Margin = 15.31% (Net Income TTM 85.2m / Revenue TTM 556.6m)
Gross Margin = 39.95% ((Revenue TTM 556.6m - Cost of Revenue TTM 334.2m) / Revenue TTM)
Gross Margin QoQ = 46.04% (prev 38.79%)
Tobins Q-Ratio = 3.38 (Enterprise Value 3.51b / Total Assets 1.04b)
Interest Expense / Debt = 2.68% (Interest Expense 201k / Debt 7.50m)
Taxrate = 17.48% (10.2m / 58.1m)
NOPAT = 79.6m (EBIT 96.5m * (1 - 17.48%))
Current Ratio = 5.61 (Total Current Assets 684.0m / Total Current Liabilities 121.9m)
Debt / Equity = 0.01 (Debt 7.50m / totalStockholderEquity, last quarter 910.2m)
Debt / EBITDA = -0.89 (Net Debt -100.6m / EBITDA 113.2m)
Debt / FCF = -0.55 (Net Debt -100.6m / FCF TTM 181.8m)
Total Stockholder Equity = 867.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.28% (Net Income 85.2m / Total Assets 1.04b)
RoE = 9.82% (Net Income TTM 85.2m / Total Stockholder Equity 867.9m)
RoCE = 11.06% (EBIT 96.5m / Capital Employed (Equity 867.9m + L.T.Debt 4.63m))
RoIC = 9.15% (NOPAT 79.6m / Invested Capital 869.9m)
WACC = 9.00% (E(3.73b)/V(3.74b) * Re(9.01%) + D(7.50m)/V(3.74b) * Rd(2.68%) * (1-Tc(0.17)))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.11%
[DCF] Terminal Value 66.26% ; FCFF base≈181.8m ; Y1≈119.4m ; Y5≈54.6m
[DCF] Fair Price = 9.05 (EV 919.9m - Net Debt -100.6m = Equity 1.02b / Shares 112.8m; r=9.00% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 4.56 | EPS CAGR: 40.54% | SUE: 2.49 | # QB: 1
Revenue Correlation: 42.40 | Revenue CAGR: 22.05% | SUE: 2.77 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.09 | Chg7d=+0.000 | Chg30d=-0.048 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=0.63 | Chg7d=+0.000 | Chg30d=-0.008 | Revisions Net=+1 | Growth EPS=-17.1% | Growth Revenue=-4.4%
EPS next Year (2027-12-31): EPS=1.01 | Chg7d=+0.001 | Chg30d=+0.064 | Revisions Net=+7 | Growth EPS=+59.8% | Growth Revenue=+25.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.7% (Discount Rate 9.0% - Earnings Yield 2.3%)
[Growth] Growth Spread = -25.0% (Analyst -18.3% - Implied 6.7%)